• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DATASCOPE CORP. - MAHWAH CARDIOSAVE HYBRID TYPE J PLUG; SYSTEM, BALLOON, INTRA-AORTIC AND CONTROL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DATASCOPE CORP. - MAHWAH CARDIOSAVE HYBRID TYPE J PLUG; SYSTEM, BALLOON, INTRA-AORTIC AND CONTROL Back to Search Results
Model Number 0998-00-0800-32
Device Problems Overheating of Device (1437); Pumping Stopped (1503); Appropriate Term/Code Not Available (3191)
Patient Problems Cyanosis (1798); Tachycardia (2095); Ventricular Fibrillation (2130); Cardiogenic Shock (2262); Cognitive Changes (2551); Cardiovascular Insufficiency (4445)
Event Date 07/25/2023
Event Type  Death  
Manufacturer Narrative
Due to character restrictions in block e1 initial reporter : (b)(6).Due to character restrictions in block e1 event site name : (b)(6).Due to character restrictions in block e1 phone #: (b)(6).A supplemental report will be submitted upon completion of our investigation.
 
Event Description
The patient evolved with worsening cardiac output (up to 2.5 l/min) when presented nausea, vomiting and in the sequence 2 episodes of seizure, brief lasting about 30 seconds, with posture in flexion of the mmss and eye movements.Ecg was run, maintaining the brd pattern (and first-degree avb), and requested troponin which was only slightly increased 0.44.After the second seizure, the patient returned making cyanosis of the extremities and liver, with a significant worsening of the pattern ventilator, so it was decided to proceed with orotracheal intubation.Patient was intubated in rapid sequence, with fentanyl, ketamine, etomidate and rocuronium, with tube 8.5, uneventful.Tube fixed at mark 22 on the labial rhyme.Having made contact with the routine and in view of the clinical worsening (intermacs 2) it was decided to pass an intra-aortic balloon through the left femoral artery.Requested and checked rx control chest for balloon positioning.After start of assistance with the balloon, 1:1, there was an improvement in the liver and pulmonary auscultation.The cardiosave intra-aortic balloon pump (iabp) unit's presented the fault "system overheating", stopped inflating the balloon and presented the fault "automatic deflation of the r wave".From then on, the system itself indicated actions that could be taken, asking to turn off the bbia, wait 10 seconds and then turn it on again.This procedure was performed three times, increasing the interval between turning off and on the bbia, in the last test the 10min interval to reconnect the bbia, all unsuccessful attempts.When turning the system back on, the system overheating fault persisted, the exhaust cooler was evaluated and it was operational.After performing the procedure of turning the bbia off and on again three times, the medical team decided to remove the balloon from the patient.After stopping therapy there was a need for increased dose of inotropic and vasopressor.Patient was sedated hypocolored hydrated eupneic acyanotic.The patient expired less than 48 hours after removal of the iabp.
 
Manufacturer Narrative
Getinge field service engineer (fse) was dispatched again to evaluate the iabp unit and was at first unable to reproduce the reported issue.The next day, the fse was able to reproduce the reported failure.The unit has been investigated tested and calibrated according to the procedures in the service manual.The affected unit will be sent back to the factory for root cause investigation.The equipment has not been released for clinical use.The customer will be receiving a replacement device in the interim.
 
Event Description
N/a.
 
Manufacturer Narrative
Getinge field service engineer (fse) was dispatched to evaluate the iabp unit and was unable to reproduce the reported issue.The unit has been investigated tested and calibrated according to the procedures in the service manual.No technical findings were reported and the device has been released for clinical use.
 
Event Description
The patient evolved with worsening cardiac output (up to 2.5 l/min) when presented nausea, vomiting and in the sequence 2 episodes of seizure, brief lasting about 30 seconds, with posture in flexion of the mmss and eye movements.Ecg was run, maintaining the brd pattern (and first-degree avb), and requested troponin which was only slightly increased 0.44.After the second seizure, the patient returned making cyanosis of the extremities and liver, with a significant worsening of the pattern ventilator, so it was decided to proceed with orotracheal intubation.Patient was intubated in rapid sequence, with fentanyl, ketamine, etomidate and rocuronium, with tube 8.5, uneventful.Tube fixed at mark 22 on the labial rhyme.Having made contact with the routine and in view of the clinical worsening (intermacs 2) it was decided to pass an intra-aortic balloon through the left femoral artery.Requested and checked rx control chest for balloon positioning.After start of assistance with the balloon, 1:1, there was an improvement in the liver and pulmonary auscultation.The cardiosave intra-aortic balloon pump (iabp) unit's presented the fault "system overheating", stopped inflating the balloon and presented the fault "automatic deflation of the r wave".From then on, the system itself indicated actions that could be taken, asking to turn off the bbia, wait 10 seconds and then turn it on again.This procedure was performed three times, increasing the interval between turning off and on the bbia, in the last test the 10min interval to reconnect the bbia, all unsuccessful attempts.When turning the system back on, the system overheating fault persisted, the exhaust cooler was evaluated and it was operational.After performing the procedure of turning the bbia off and on again three times, the medical team decided to remove the balloon from the patient.After requesting further details that may have contributed to the system overheat, it was reported the patient was tachycardic, cyanotic and hemodynamically unstable.He remained on mechanical ventilation, and was neurologically unstable with a glasgow coma scale of 3 with fixed pupils.He was supported on both inotropic and vasopressor infusions, in an irregular cardiac rhythm (¿ventricular coupling¿) with a maximal heart rate reported at 111 beats per minute.Following the ¿console overheat¿ alarm and the cessation of therapy on (b)(6) 2023 at 4:40 am, the patient was reported to require increased vasopressor and inotropic support, but remained clinically stable on low dose pressor and inotropes (norepinephrine, vasopressin and dobutamine).Seven hours following therapy cessation at 21:49 it was reported that the patient had developed ¿hemodynamic instability and refractory shock¿, with a ¿mottled¿ presentation, distal cyanosis and decreased peripheral perfusion, acute renal failure as evidenced by oliguria (270 ml in twelve hours); requiring high dose norepinephrine, vasopressin and dobutamine.It was subsequently reported that the patient expired more than 24 hours later on (b)(6) 2023 at 19:15.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOSAVE HYBRID TYPE J PLUG
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC AND CONTROL
Manufacturer (Section D)
DATASCOPE CORP. - MAHWAH
1300 macarthur blvd
mahwah NJ
Manufacturer (Section G)
DATASCOPE CORP. - MAHWAH
1300 macarthur blvd
mahwah NJ
Manufacturer Contact
arelean guzman
1300 macarthur blvd
mahwah, NJ 
MDR Report Key17510837
MDR Text Key320893962
Report Number2249723-2023-03631
Device Sequence Number1
Product Code DSP
UDI-Device Identifier10607567111117
UDI-Public10607567111117
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K112372
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0998-00-0800-32
Device Catalogue Number0998-00-0800-32
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/10/2019
Is the Device Single Use? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
7.5 FR. 34CC MAQUET BALLOON.
Patient Outcome(s) Death;
Patient Age77 YR
Patient SexMale
Patient Weight93 KG
-
-